Showing results (161-170 of 267) with videos related to

Sort By:
Pageof 27
Blood|September 21, 2005
Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension studyJane S Hankins, Russell E Ware, Zora R Rogers, et al.
Blood|April 17, 2010
Pulmonary hypertension and nitric oxide depletion in sickle cell diseaseH Franklin Bunn, David G Nathan, George J Dover, et al.
Blood Advances|January 4, 2018
Whole-exome sequencing for RH genotyping and alloimmunization risk in children with sickle cell anemiaStella T Chou, Jonathan M Flanagan, Sunitha Vege, et al.
British Journal of Haematology|July 8, 2024
A pharmacokinetic-pharmacodynamic analysis of l-glutamine for the treatment of sickle cell disease: Implications for understanding the mechanism of action and evaluating response to therapyAlina Sadaf, Min Dong, Amanda Pfeiffer, et al.
The Journal of Pediatrics|October 20, 2015
A Cost-Effectiveness Analysis of a Pilot Neonatal Screening Program for Sickle Cell Anemia in the Republic of AngolaPatrick T McGann, Scott D Grosse, Brigida Santos, et al.
Pharmacoeconomics|July 18, 2023
Cost-Effectiveness of Hydroxyurea for Sickle Cell Anemia in a Low-Income African Setting: A Model-Based Evaluation of Two Dosing RegimensDavid Teigen, Robert O Opoka, Phillip Kasirye, et al.
American Journal of Hematology|April 23, 2013
Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypesVivien A Sheehan, Zhaoyu Luo, Jonathan M Flanagan, et al.
Mutation Research|March 17, 2010
Assessment of genotoxicity associated with hydroxyurea therapy in children with sickle cell anemiaJonathan M Flanagan, Thad A Howard, Nicole Mortier, et al.
Pediatric Blood & Cancer|July 27, 2010
Ventricular diastolic dysfunction in sickle cell anemia is common but not associated with myocardial iron depositionJane S Hankins, Mary Beth McCarville, Claudia M Hillenbrand, et al.
The Journal of Clinical Investigation|December 14, 2011
In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technologyMichelle Tsai, Ashley Kita, Joseph Leach, et al.
Pageof 27